These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26170639)

  • 1. Defining medication adherence in individual patients.
    Morrison A; Stauffer ME; Kaufman AS
    Patient Prefer Adherence; 2015; 9():893-7. PubMed ID: 26170639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization and adherence patterns of subcutaneously administered anti-tumor necrosis factor treatment among rheumatoid arthritis patients.
    Tkacz J; Ellis L; Bolge SC; Meyer R; Brady BL; Ruetsch C
    Clin Ther; 2014 May; 36(5):737-47. PubMed ID: 24661783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of serum concentrations of adalimumab as predictor of treatment adherence.
    Sáez Belló M; Llopis Salvia P; Alegre Sancho JJ; Paredes Arquiola JM; Asencio Muñoz MDC; Climente Martí M
    Reumatol Clin (Engl Ed); 2020; 16(1):32-37. PubMed ID: 29500118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Let Visuals Tell the Story: Medication Adherence in Patients with Type II Diabetes Captured by a Novel Ingestion Sensor Platform.
    Browne SH; Behzadi Y; Littlewort G
    JMIR Mhealth Uhealth; 2015 Dec; 3(4):e108. PubMed ID: 26721413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
    Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK
    Clin Ther; 2003 Jun; 25(6):1700-21. PubMed ID: 12860493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study.
    Marshall JK; Bessette L; Thorne C; Shear NH; Lebovic G; Gerega SK; Millson B; Oraichi D; Gaetano T; Gazel S; Latour MG; Laliberté MC
    Clin Ther; 2018 Mar; 40(3):415-429.e6. PubMed ID: 29519714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: analysis from a Canadian administrative database.
    Bhoi P; Bessette L; Bell MJ; Tkaczyk C; Nantel F; Maslova K
    BMJ Open; 2017 Sep; 7(9):e015872. PubMed ID: 28928177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasis.
    Gniadecki R; Leonardi CL; Gordon KB; Gu Y; Geng Z; Nader A; Teixeira HD
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1297-1304. PubMed ID: 29524255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of medication dosing frequency on adherence in chronic diseases.
    Saini SD; Schoenfeld P; Kaulback K; Dubinsky MC
    Am J Manag Care; 2009 Jun; 15(6):e22-33. PubMed ID: 19514806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of clozapine in serum of patients with schizophrenia as a measurement of medication compliance.
    Mennickent S; Sobarzo A; Vega M; de Diego M; Godoy G; Rioseco P; Saavedra L
    Int J Psychiatry Clin Pract; 2010 Mar; 14(1):41-6. PubMed ID: 24917231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to adalimumab in patients with moderate to severe psoriasis.
    West C; Narahari S; O'Neill J; Davis S; Huynh M; Clark A; Boles A; Feldman SR
    Dermatol Online J; 2013 May; 19(5):18182. PubMed ID: 24011280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication adherence and persistence in the treatment of rheumatoid arthritis with adalimumab and etanercept. Six years of analysis.
    Santoleri F; Sorice P; Lasala R; Rizzo RC; Costantini A
    J Med Econ; 2014 May; 17(5):320-5. PubMed ID: 24641160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study.
    Marshall JK; Bessette L; Shear NH; Lebovic G; Glass J; Millson B; Gaetano T; Gazel S; Latour MG; Laliberté MC; Thorne JC
    Clin Ther; 2018 Jun; 40(6):1024-1032. PubMed ID: 29803532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review of Medication Adherence Thresholds Dependent of Clinical Outcomes.
    Baumgartner PC; Haynes RB; Hersberger KE; Arnet I
    Front Pharmacol; 2018; 9():1290. PubMed ID: 30524276
    [No Abstract]   [Full Text] [Related]  

  • 15. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients.
    Carter CT; Changolkar AK; Scott McKenzie R
    J Med Econ; 2012; 15(2):332-9. PubMed ID: 22168788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women.
    Recker RR; Gallagher R; MacCosbe PE
    Mayo Clin Proc; 2005 Jul; 80(7):856-61. PubMed ID: 16007889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between trough serum levels of adalimumab and absolute PASI score in a series of patients with psoriasis.
    Carrascosa JM; Toro Montecinos M; Ballescá F; Teniente Serra A; Martínez Cáceres E; Ferrándiz C
    J Dermatolog Treat; 2018 Mar; 29(2):140-144. PubMed ID: 28604127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis.
    Weeda ER; Coleman CI; McHorney CA; Crivera C; Schein JR; Sobieraj DM
    Int J Cardiol; 2016 Aug; 216():104-9. PubMed ID: 27144286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.